BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Don’t Stop Believing: Teva’s R&D Head Gives 3 Reasons Why Investors Should Hold On

  Teva’s stock jumped as investors get more hopeful about the future.

  November 16, 2017

   · 

  1 min read
• 

  FDA

  On a Roll: FDA OKs Genentech’s Gazyva for Untreated Follicular Lymphoma

  Genentech scored two approvals from the FDA this week.

  November 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Berates Lupin for Repeatedly Making Pills That Don’t Meet Quality Standards

  In 2015 and 2016, the FDA found 134 instances when drugs or active ingredients failed initial testing but the company chose to override the results.

  November 16, 2017

   · 

  1 min read
• 

  Business

  Kendall Square Startup Cue Biopharma Scores $374M R&D Pact With Merck

  Under the deal, CUE will leverage its CUE Biologics platform to develop biologics engineered to affect specific T-cell subpopulations to treat autoimmune diseases.

  November 16, 2017

   · 

  2 min read

   · 

  Mark Terry
• Pharm Country

  Thetis Pharmaceuticals Awarded $2.3M Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel Disease

  Resolvin-based agent targets inflammation resolution and tissue regeneration without immunosuppression.

  November 16, 2017

   · 

  2 min read
• 

  FDA

  FDA Approves Genentech’s Hemlibra, the First Drug in 20 Years for Hemophilia A With Inhibitors

  The drug will be used to prevent or reduce the frequency of bleeding episodes in certain patients.

  November 16, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  All Systems Go: Johnson & Johnson Reaches Out for Second Ionis GI Drug

  Ionis Pharma and Janssen have strengthened their alliance with a second deal for gastrointestinal drugs.

  November 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Founded by Genzyme Alumni, Cambridge’s X4 Pharma Scores $27M

  The company plans to use the cash to advance its two lead drug programs into the clinic.

  November 16, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  Pfizer Wins Expanded FDA Nod for Cancer Drug Sutent

  The FDA approved a label expansion for Pfizer’s cancer drug Sutent to include the adjuvant treatment of adult patients at high risk of RCC following the surgical removal of the cancerous kidney.

  November 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Regeneron Gets OK for Huge Expansion in Greenburgh, New York

  When complete, the expansion is expected to double the size of Regeneron’s footprint in Greenburgh.

  November 16, 2017

   · 

  2 min read

   · 

  Alex Keown